Xi'an Manareco issued a profit forecast, expecting a net profit attributable to the parent company of 162 million yuan in the first half of the year, a year-on-year increase of 69.93%
I'm LongbridgeAI, I can summarize articles.Xi'an Manareco expects a net profit attributable to the parent company of 162 million yuan in the first half of 2025, a year-on-year increase of 69.93%. The company's pharmaceutical segment revenue has increased significantly, product structure changes have improved the overall gross profit margin, and cost control has been strengthened to enhance profitability
According to the Zhitong Finance APP, Xi'an Manareco (688550.SH) announced that it expects to achieve a net profit attributable to the parent company's owners of 162 million yuan in the first half of 2025, an increase of 66.6618 million yuan compared to the same period last year, representing a year-on-year growth of 69.93%.
In the first half of the year, the company's pharmaceutical segment saw significant revenue growth year-on-year, and changes in product structure further boosted the overall gross profit margin. At the same time, the company continues to strengthen cost control, reduce costs, and improve efficiency, enhancing its profitability